Clinical Trial

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Study acronym: FILRA
Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Purpose: The study aims to investigate how Filgotinib affects proteins and micro-RNA in the blood of patients with rheumatoid arthritis. This could help understand its impact on inflammation and bone health in these patients. Study Design: This is a single-center, prospective randomized study.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06527534
Lead Sponsor Universita di Verona
Conditions Rheumatoid Arthritis
Enrollment 30 participants
Start Date 2024-07-15
Primary Completion 2025-07-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-08-01